These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19618305)

  • 1. The Third International Stroke Trial: Thrombolysis (IST-3) in Poland: are we recruiting the right patients?
    Członkowska A; Kobayashi A; Lewis S; Sanderock P; Lindley R; Barańska-Gierszczak M
    Neurol Neurochir Pol; 2009; 43(3):228-35. PubMed ID: 19618305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intravenous thrombolysis in the treatment of acute ischaemic stroke: 3, 4.5, or 6 hours?].
    Kwieciński H
    Neurol Neurochir Pol; 2009; 43(3):213-5. PubMed ID: 19618303
    [No Abstract]   [Full Text] [Related]  

  • 3. Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment.
    Huang Y; Sharma VK; Robinson T; Lindley RI; Chen X; Kim JS; Lavados P; Olavarría V; Arima H; Fuentes S; Nguyen HT; Lee TH; Parsons MW; Levi C; Demchuk AM; Bath PM; Broderick JP; Donnan GA; Martins S; Pontes-Neto OM; Silva F; Pandian J; Ricci S; Stapf C; Woodward M; Wang J; Chalmers J; Anderson CS;
    Int J Stroke; 2015 Jul; 10(5):778-88. PubMed ID: 25832995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Estimation of patient eligibility for thrombolysis in acute ischaemic stroke based on a hospital stroke registry in Warsaw].
    Kobayashi A; Sarzyńska-Długosz I; Niewada M; Skowrońska M; Członkowska A
    Neurol Neurochir Pol; 2006; 40(5):369-75. PubMed ID: 17103349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes (the third International Stroke Trial [IST-3]): 18-month follow-up of a randomised controlled trial.
    IST-3 collaborative group
    Lancet Neurol; 2013 Aug; 12(8):768-76. PubMed ID: 23791822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited.
    Sandercock P; Lindley R; Wardlaw J; Dennis M; Innes K; Cohen G; Whiteley W; Perry D; Soosay V; Buchanan D; Venables G; Czlonkowska A; Kobayashi A; Berge E; Slot KB; Murray V; Peeters A; Hankey GJ; Matz K; Brainin M; Ricci S; Cantisani TA; Gubitz G; Phillips SJ; Antonio A; Correia M; Lyrer P; Kane I; Lundstrom E;
    Trials; 2011 Nov; 12():252. PubMed ID: 22129158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous thrombolysis for acute ischaemic stroke in patients not fully adhering to the European licence in Poland.
    Karliński M; Kobayashi A; Litwin T; Sobolewski P; Fryze W; Romanowicz S; Glonek M; Nyka W; Lisewski P; Członkowska A;
    Neurol Neurochir Pol; 2012; 46(1):3-14. PubMed ID: 22426757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can we extend thrombolysis indications for acute ischaemic stroke? The IST-3 study.
    Del Medico M; Bonura A;
    Intern Emerg Med; 2013 Apr; 8(3):261-2. PubMed ID: 23456848
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravenous recombinant tissue plasminogen activator for acute stroke in Poland: an analysis based on the Safe Implementation of Thrombolysis in Stroke (SITS) Registry.
    Kobayashi A; Czlonkowska A; Ahmed N; Romanowicz S; Glonek M; Nyka WM; Opala G; Wahlgren N;
    Acta Neurol Scand; 2010 Oct; 122(4):229-36. PubMed ID: 19919643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
    Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
    JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Nitric Oxide in Stroke - a randomized trial. Characteristics of patients recruited in Poland.
    Kobayashi A; Członkowska A; Grabska K; Staszewski J; Kotowicz J; Gray LJ; Bath PM
    Neurol Neurochir Pol; 2008; 42(2):99-104. PubMed ID: 18512165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of experience of intravenous thrombolysis for acute ischaemic stroke does not influence the proportion of patients treated.
    Kobayashi A; Skowronska M; Litwin T; Czlonkowska A
    Emerg Med J; 2007 Feb; 24(2):96-9. PubMed ID: 17251612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posterior vs. anterior circulation infarction: demography, outcomes, and frequency of hemorrhage after thrombolysis.
    Dorňák T; Král M; Hazlinger M; Herzig R; Veverka T; Buřval S; Šaňák D; Zapletalová J; Antalíková K; Kaňovský P
    Int J Stroke; 2015 Dec; 10(8):1224-8. PubMed ID: 26310390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical Trial.
    Khatri P; Kleindorfer DO; Devlin T; Sawyer RN; Starr M; Mejilla J; Broderick J; Chatterjee A; Jauch EC; Levine SR; Romano JG; Saver JL; Vagal A; Purdon B; Devenport J; Pavlov A; Yeatts SD;
    JAMA; 2018 Jul; 320(2):156-166. PubMed ID: 29998337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous thrombolysis with recombinant tissue plasminogen activator in vascular warning syndromes.
    González Hernández A; Fabre Pi O; Cabrera Naranjo F; López Veloso AC
    Neurologia; 2014; 29(6):334-8. PubMed ID: 24139385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High early case fatality after ischaemic stroke in Poland: exploration of possible explanations in the International Stroke Trial.
    Członkowska A; Niewada M; Saleh El-Baroni I; Mendel T; Ryglewicz D; Sandercock P; Lewis S
    J Neurol Sci; 2002 Oct; 202(1-2):53-7. PubMed ID: 12220692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posterior circulation stroke is associated with prolonged door-to-needle time.
    Sarraj A; Medrek S; Albright K; Martin-Schild S; Bibars W; Vahidy F; Grotta JC; Savitz SI
    Int J Stroke; 2015 Jul; 10(5):672-8. PubMed ID: 23521891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous Thrombolysis for Stroke Recurring Within 3 Months From the Previous Event.
    Karlinski M; Kobayashi A; Czlonkowska A; Mikulik R; Vaclavik D; Brozman M; Gdovinova Z; Švigelj V; Csiba L; Fekete K; Kõrv J; Demarin V; Bašic-Kes V; Vilionskis A; Jatuzis D; Krespi Y; Shamalov N; Andonova S; Ahmed N; Wahlgren N;
    Stroke; 2015 Nov; 46(11):3184-9. PubMed ID: 26451024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial.
    Anderson CS; Huang Y; Lindley RI; Chen X; Arima H; Chen G; Li Q; Billot L; Delcourt C; Bath PM; Broderick JP; Demchuk AM; Donnan GA; Durham AC; Lavados PM; Lee TH; Levi C; Martins SO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Silva F; Song L; Thang NH; Wardlaw JM; Wang JG; Wang X; Woodward M; Chalmers J; Robinson TG;
    Lancet; 2019 Mar; 393(10174):877-888. PubMed ID: 30739745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised controlled trial of antiplatelet therapy in combination with Rt-PA thrombolysis in ischemic stroke: rationale and design of the ARTIS-Trial.
    Zinkstok SM; Vermeulen M; Stam J; de Haan RJ; Roos YB;
    Trials; 2010 May; 11():51. PubMed ID: 20459856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.